Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	65.68	-514.35	310.44
Graham Fair Price	25.77	1.09	0.86
PEG	-75.18	0.43	-1.74
Price/Book	-10.64	3.99	4.46
Price/Cash Flow	13386.83	1215.98	-9.02
Prices/Earnings	-43.10	-63.86	112.23
Price/Sales	-6.44	2.91	3.11
Price/FCF	13386.83	1215.98	-9.02
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	8.10	0.08	0.07
Operating Margin	-286.40	-0.01	< 0.005
ROA	51.95	< 0.005	< 0.005
ROE	< 0.005	-0.02	57.05
ROIC	< 0.005	-0.02	-617.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	0.15	-0.22	-30.98
Dividends QOQ	-0.17	-0.10	40.47
EBIT QOQ	-1.10	-1.36	-23.62
EPS QOQ	-0.64	-1.48	-129.28
FCF QOQ	-2.33	-0.92	60.43
Revenue QOQ	-0.04	-0.22	-463.18
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.52	40.06	1.38
Days Sales Outstanding (DSO)	186.06	11.43	-93.86
Inventory Turnover	2.28	2.25	-1.36
Debt/Capitalization	0.42	0.31	-24.52
Quick Ratio	0.83	0.92	11.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	1.82	1.96	7.36
Cash	0.48	0.74	52.69
Capex	< 0.005	< 0.005	-55.38
Free Cash Flow	-0.90	< 0.005	-99.34
Revenue	2.62	2.51	-4.14
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.06	1.06	-0.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	28.22	-20.06	-28.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating